Temozolomide‐Induced Desquamative Skin Rash in a Patient with Metastatic Melanoma
AM Pick, WJ Neff, KK Nystrom - Pharmacotherapy: The Journal …, 2008 - Wiley Online Library
Temozolomide is an oral alkylating agent used in the treatment of metastatic melanoma.
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma
AM Pick, WJ Neff, KK Nystrom - Pharmacotherapy, 2008 - pubmed.ncbi.nlm.nih.gov
Temozolomide is an oral alkylating agent used in the treatment of metastatic melanoma.
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
[引用][C] Temozolomide-Induced Desquamative Skin Rash in a Patient with Metastatic Melanoma
AM PICK, WJ NEFF, KK NYSTROM - Pharmacotherapy, 2008 - pascal-francis.inist.fr
Temozolomide-Induced Desquamative Skin Rash in a Patient with Metastatic Melanoma CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[引用][C] Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma
AM Pick, WJ Neff, KK Nystrom - Pharmacotherapy, 2008 - researchworks.creighton.edu
Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma
AM Pick, WJ Neff, KK Nystrom - Pharmacotherapy, 2008 - experts.nebraska.edu
Temozolomide is an oral alkylating agent used in the treatment of metastatic melanoma.
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma.
AM Pick, WJ Neff, KK Nystrom - Pharmacotherapy, 2008 - europepmc.org
Temozolomide is an oral alkylating agent used in the treatment of metastatic melanoma.
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …
Commonly reported adverse effects of the drug include nausea and vomiting, constipation …